Adalvo
Manufacturing · Malta · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Malta Life Science Park Building 1 L 4, ...Phone Number
+356 22485944Website
www.adalvo.comRevenue
$101.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
1
1
1
1
About Adalvo
Adalvo is a global pharmaceutical company dedicated to improving the lives of patients worldwide through high-quality differentiated products and services. The company emphasizes a strong commitment to its partner network, ensuring that they are always on target in their mission. Adalvo's purpose-driven culture fosters excellence and inspires strategic choices that lead to positive changes in healthcare. Their team is composed of industry experts who align their capabilities with the business goals of their partners.Explore more
Adalvo Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Adalvo your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Adalvo recently announced quarterly report
Adalvo, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Adalvo is spiking on competitors!
Funding: Get notified immidiatlly once Adalvo has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Adalvo
Product Launch: Get notified when Adalvo launches new products
Click to see if Adalvo had a recent Job posting/layoffs
Check if Adalvo has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Adalvo
Find more new buyers
Company Profile Activity
Activity Insights
Adalvo is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Adalvo is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Adalvo.
Adalvo Tech Stack
A closer look at the technologies used by Adalvo
See more technologies
Most Recent Scoops
Hiring Plans
Adalvo has more open roles in Marketing than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
Adalvo has more open roles in Finance than it has had at any time in the past 12 months. Technologies mentioned include: Power BI.
Hiring Plans
Event
Product Marketing, Events, Training, Sales, Logistics / Supply Chain, Pharmaceuticals, Clinical Operations, Field Marketing, Manufacturing Operations, Operations
Hiring Plans
Adalvo has more open roles in Legal than it has had at any time in the past 12 months.
Hiring Plans
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Adalvo News & Media
EQT to acquire Adalvo, a leading B2B dossier developer
EQT X to acquire Adalvo, a rapidly growing, asset-light B2B dossier developer providing market-approval-ready generic drug dossiers to pharmaceutical companies EQT will support Adalvo's next phase of growth, further investing in R&D and innovation, and advancing the operational scale-up...Aztiq sells Adalvo to EQT
Aztiq sells Adalvo, one of the leading business-to-business pharmaceutical companies in Europe founded in 2018, to EQT, a global investment organization.Formosa Pharmaceuticals and Adalvo Limited Announce Licensing Agreement for Clobetasol Propionate Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain
TAIPEI, May 28, 2025 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Adalvo Limited ("Adalvo") in the European and Brazilian markets for exclusive rights to the commercialization of clobetasol propionate ophthalmic suspension, 0.05% (APP13007), a marketed innovative treatment of post-operative inflammation and pain following ocular surgery. Adalvo, a global pharma and top-three B2B company
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Adalvo
Sign Up For FreeTo access detailed company insights
Adalvo is a global pharmaceutical company dedicated to improving the lives of patients worldwide through high-quality differentiated products and services. The company emphasizes a strong commitment to its partner network, ensuring that they are always on target in their mission. Adalvo's purpose-driven culture fosters excellence and inspires strat... Read More
